Swiss National Bank

Bank

Position in PGEN — Precigen, Inc.

CIK 1582202 ZURICH, V8

Position in PGEN

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$1,350,630

-$108,190 QoQ

Shares Held

349,000

0.0% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. PGEN ranks #112 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,600	$332,493,684
2	REGN	Regeneron Pharmaceuticals, Inc.	303,140	$234,218,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	387,720	$128,284,916
4	INSM	INSMED Inc	625,912	$102,349,130
5	RPRX	Royalty Pharma plc	1,191,100	$57,137,067
6	INCY	Incyte Corp	489,774	$46,097,528
7	RVMD	Revolution Medicines, Inc.	425,431	$41,373,164
8	MRNA	Moderna, Inc.	696,100	$35,361,880

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,350,630	349,000	0.0%	Shares	Sole	2026-05-07
2025-12-31	$1,458,820	349,000	+7.4%	Shares	Sole	2026-02-12
2023-03-31	$344,500	325,000	+33.4%	Shares	Sole	2023-05-10
2022-12-31	$370,424	243,700	0.0%	Shares	Sole	2023-02-08
2022-09-30	$516,644	243,700	0.0%	Shares	Sole	2022-11-09
2022-06-30	$326,558	243,700	+10.8%	Shares	Sole	2022-08-09
2022-03-31	$464,200	220,000	+7.2%	Shares	Sole	2022-05-09
2021-12-31	$761,663	205,300	0.0%	Shares	Sole	2022-02-08
2021-09-30	$1,024,447	205,300	+2.1%	Shares	Sole	2021-11-08
2021-06-30	$1,311,172	201,100	+18.6%	Shares	Sole	2021-08-06
2021-03-31	$1,167,855	169,500	+9.4%	Shares	Sole	2021-05-07
2020-12-31	$1,581,000	155,000	0.0%	Shares	Sole	2021-02-05
2020-09-30	$542,500	155,000	+6.8%	Shares	Sole	2020-11-09
2020-06-30	$724,049	145,100	+3.9%	Shares	Sole	2020-08-05
2020-03-31	$474,980	139,700	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.